Department of Cardiac Surgery, University of Michigan Frankel Cardiovascular Center, Ann Arbor, Mich.
Department of Cardiac Surgery, University of Michigan Frankel Cardiovascular Center, Ann Arbor, Mich.
J Thorac Cardiovasc Surg. 2022 Sep;164(3):981-993.e8. doi: 10.1016/j.jtcvs.2020.12.123. Epub 2021 Jan 12.
The study objective was to determine the influence of allograft ischemic time on heart transplant outcomes among ABO donor organ types given limited prior reports of its survival impact.
We identified 32,454 heart transplants (2000-2016) from the United Network for Organ Sharing database. Continuous and categoric variables were analyzed by parametric and nonparametric testing. Survival was determined using log-rank or Cox regression tests. Propensity matching adjusted for preoperative variables.
By comparing allograft ischemic time less than 4 hours (n = 6579) with 4 hours or more (n = 25,875), the hazard ratios for death at 15 years after prolonged ischemic time (≥4 hours) for blood types O, A, B, and AB were 1.106 (P < .001), 1.062 (P < .001), 1.059 (P = .062), and 1.114 (P = .221), respectively. Unadjusted data demonstrated higher mortality for transplantation of O versus non-O donor hearts for ischemic time 4 hours or more (hazard ratio, 1.164; P < .001). After propensity matching, O donor hearts continued to have worse survival if preserved for 4 hours or more (hazard ratio, 1.137, P = .008), but not if ischemic time was less than 4 hours (hazard ratio, 1.042, P = .113). In a matched group with 4 hours or more of ischemic time, patients receiving O donor organs were more likely to experience death from primary graft dysfunction (2.5% vs 1.7%, P = .052) and chronic allograft rejection (1.9% vs 1.1%, P = .021). No difference in death from primary graft dysfunction or chronic allograft rejection was seen with less than 4 hours of ischemic time (P > .150).
Compared with non-O donor hearts, transplantation with O donor hearts with ischemic time 4 hours or more leads to worse survival, with higher rates of primary graft dysfunction and chronic rejection. Caution should be practiced when considering donor hearts with the O blood type when anticipating extended cold ischemic times.
本研究旨在确定供体器官 ABO 血型对同种异体移植物缺血时间的影响,因为之前的研究报道较少涉及该因素对移植结局的生存影响。
我们从美国器官共享网络数据库中确定了 32454 例心脏移植(2000-2016 年)。采用参数和非参数检验分析连续和分类变量。采用对数秩或 Cox 回归检验确定生存率。采用倾向评分匹配调整术前变量。
与缺血时间小于 4 小时(n=6579)相比,缺血时间大于等于 4 小时(n=25875)的 O、A、B 和 AB 血型的同种异体移植物 15 年死亡的危险比分别为 1.106(P<0.001)、1.062(P<0.001)、1.059(P=0.062)和 1.114(P=0.221)。未校正数据显示,缺血时间大于等于 4 小时时,O 型供体心脏移植的死亡率高于非 O 型供体心脏(危险比,1.164;P<0.001)。在进行倾向评分匹配后,如果同种异体移植物保存时间大于等于 4 小时,O 型供体心脏的存活率仍较差(危险比,1.137,P=0.008),但如果缺血时间小于 4 小时,其存活率无差异(危险比,1.042,P=0.113)。在缺血时间大于等于 4 小时的匹配组中,接受 O 型供体器官的患者更有可能发生原发性移植物功能障碍(2.5%比 1.7%,P=0.052)和慢性移植物排斥(1.9%比 1.1%,P=0.021)。在缺血时间小于 4 小时的情况下,原发性移植物功能障碍或慢性移植物排斥的死亡差异无统计学意义(P>0.150)。
与非 O 型供体心脏相比,O 型供体心脏在缺血时间大于等于 4 小时的情况下移植,其存活率较差,原发性移植物功能障碍和慢性排斥反应的发生率较高。当预计同种异体移植物冷缺血时间延长时,应谨慎考虑 O 型血供体心脏。